Westside Investment Management, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2023$05000.0%0.00%
Q2 2023$05000.0%0.00%
Q1 2023$05000.0%0.00%
Q4 2022$05000.0%0.00%
Q3 2022$05000.0%0.00%
Q2 2022$05000.0%0.00%
Q1 2022$05000.0%0.00%
Q4 2021$05000.0%0.00%
Q3 2021$05000.0%0.00%
Q2 2021$05000.0%0.00%
Q1 2021$0
-100.0%
5000.0%0.00%
-100.0%
Q4 2020$1,235,000
-21.6%
5000.0%0.00%
+200.0%
Q3 2020$1,575,000
+8.2%
5000.0%0.00%0.0%
Q2 2020$1,455,000
-99.6%
500
-98.6%
0.00%
-99.6%
Q1 2020$405,912,000
+21263.8%
36,834
+7266.8%
0.28%
+6825.0%
Q2 2019$1,900,000
+20.3%
5000.0%0.00%
+300.0%
Q4 2018$1,580,000
+25.4%
5000.0%0.00%
Q3 2018$1,260,000
-1.6%
5000.0%0.00%
Q2 2018$1,280,000
+20.2%
5000.0%0.00%
-100.0%
Q1 2017$1,065,000
-8.2%
5000.0%0.00%0.0%
Q4 2016$1,160,0005000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,585,500$3,710,0001.36%
SMH CAPITAL ADVISORS INC 83,369$195,0000.32%
West Family Investments, Inc. 338,141$791,0000.20%
Matarin Capital Management, LLC 927,289$2,169,856,0000.16%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$33,0000.12%
Alambic Investment Management, L.P. 163,200$382,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 1,760,376$4,119,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 5,677,647$13,286,0000.08%
Zebra Capital Management LLC 67,892$159,0000.07%
Fortis Advisors, LLC 45,602$107,0000.06%
View complete list of PDL BIOPHARMA INC shareholders